Literature DB >> 7984496

Lymphoid cell subpopulations containing vasoactive intestinal peptide in the rat.

J Leceta1, M C Martinez, M Delgado, E Garrido, R P Gomariz.   

Abstract

In the present study we describe the cell types containing immunoreactive vasoactive intestinal peptide (IR-VIP) in rat thymus, spleen, and lymph nodes. Indirect immunofluorescence staining and flow cytometry indicated that all lymphoid organs studied contained VIP-positive cells, with the spleen and lymph nodes having a higher proportion than the thymus. Vasoactive intestinal peptide was found in both lymphocytes and nonlymphoid cells, lymphocytes predominating among VIP-positive cells. Double immunofluorescent staining and flow cytometry showed that all lymphoid subpopulations identified contained variable proportions of VIP-positive lymphocytes. Immunocytochemical staining of cell suspensions for both light and electron microscopy showed the cytoplasmic localization of the IR-VIP. These findings, coupled to our previous results, are consistent with the idea that VIP may have a lymphoid origin and could be active in local immune responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7984496     DOI: 10.1016/0196-9781(94)90031-0

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  6 in total

1.  Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice.

Authors:  Jian-Ming Li; Lauren Southerland; Mohammad S Hossain; Cynthia R Giver; Ying Wang; Kasia Darlak; Wayne Harris; James Waschek; Edmund K Waller
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

2.  Neuroimmune link in the mucosa of chronic gastritis with Helicobacter pylori infection.

Authors:  G Sipos; K Altdorfer; E Pongor; L P Chen; E Fehér
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

Review 3.  The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases.

Authors:  D Ganea; K M Hooper; W Kong
Journal:  Acta Physiol (Oxf)       Date:  2014-12-11       Impact factor: 6.311

4.  Pharmacological inhibition of VIP signaling enhances antiviral immunity and improves survival in murine cytomegalovirus-infected allogeneic bone marrow transplant recipients.

Authors:  Jian-Ming Li; Mohammad S Hossain; Lauren Southerland; Edmund K Waller
Journal:  Blood       Date:  2013-01-16       Impact factor: 22.113

Review 5.  Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease.

Authors:  Magdy El-Salhy; Tefera Solomon; Trygve Hausken; Odd Helge Gilja; Jan Gunnar Hatlebakk
Journal:  World J Gastroenterol       Date:  2017-07-28       Impact factor: 5.742

Review 6.  Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system.

Authors:  Mari Iwasaki; Yasutada Akiba; Jonathan D Kaunitz
Journal:  F1000Res       Date:  2019-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.